drugset

drugset / Trial / NCT00491114

Intravesical Chemotherapy Treatment of Superficial Bladder Cancer

NCT00491114 ↗

Phase 2 Completed 8 enrolled Eli Lilly and Company

Non-randomizedSingle-groupOpen-labelTreatment

Summary

This is a phase II study where chemotherapy (gemcitabine) is given into the urinary bladder.

Timeline

Start: 2003-07
Primary completion: —
Completion: 2004-08

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Gemcitabine	Small molecule	—	Other

Indications